Omada Health
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, ...
Latest News
20 days ago · globenewswire.com
Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026SAN FRANCISCO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2026 results on Thursday, November 5, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at https://investors.omadahealth.com.
1 month ago · fool.com
Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000The transaction represented 3% of the insider's direct equity holdings before the filing. The sale was conducted directly through an open-market transaction under a pre-established Rule 10b5-1 trading plan.
2 months ago · seekingalpha.com
Omada Health, Inc. (OMDA) Analyst/Investor Day TranscriptOmada Health, Inc. (OMDA) Analyst/Investor Day Transcript
2 months ago · globenewswire.com
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor DaySAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, will present its long-term financial targets at the company's inaugural Investor Day, being held today at the Four Seasons Hotel in New York, New York.
2 months ago · fool.com
Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 SharesTraded 31,457 shares with a transaction value of ~$735,150 based on a weighted average price of $23.37 per share. The activity involved shares equal to 2% of the total equity stake held before the filing, including direct transactions equal to 8% of the prior direct position.
3 months ago · seekingalpha.com
Omada Health: Q2 Shows More Evidence Of Growth Converting Into EarningsOmada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating. OMDA's product expansion, especially in diabetes and hypertension, is driving higher revenue per member and improving customer-lifetime-value through multi-program adoption. Channel partnerships with PBMs and health plans are lowering CAC, supporting scalable growth and better unit economics, while AI initiatives further enhance operational leverage.
3 months ago · zacks.com
Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesAlthough the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
3 months ago · seekingalpha.com
Omada Health, Inc. (OMDA) Q2 2026 Earnings Call TranscriptOmada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript
3 months ago · marketbeat.com
Omada Health Q2 Earnings Call HighlightsOmada Health NASDAQ: OMDA reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also announced that President Wei-Li Shao will succeed Co-founder and Chief Executive Officer Sean Duffy as CEO on Jan. 1, 2027.
3 months ago · zacks.com
Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top EstimatesOmada Health, Inc. (OMDA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.09 per share a year ago.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove OMDA